相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bone Mineral Density and Bone Turnover 10 Years After a Single 5 mg Dose or Two 5-Yearly Lower Doses of Zoledronate in Osteopenic Older Women: An Open-Label Extension of a Randomized Controlled Trial
Andrew Grey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2022)
UK clinical guideline for the prevention and treatment of osteoporosis
Celia L. Gregson et al.
ARCHIVES OF OSTEOPOROSIS (2022)
Reduction effect of oral pravastatin on the acute phase response to intravenous zoledronic acid: protocol for a real-world prospective, placebo-controlled trial
Qi Liu et al.
BMJ OPEN (2022)
Addition of dexamethasone to manage acute phase responses following initial zoledronic acid infusion
F-P Chen et al.
OSTEOPOROSIS INTERNATIONAL (2021)
THE EFFECTS OF PERIOPERATIVE DEXAMETHASONE ON GLYCEMIC CONTROL AND POSTOPERATIVE OUTCOMES
Rebecca A. Herbst et al.
ENDOCRINE PRACTICE (2020)
Efficacy of non-steroidal anti-inflammatory drugs on zoledronic acid-induced acute-phase reactions: randomized, open-label, Japanese OZ study
Nobukazu Okimoto et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2020)
Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update
Dolores Shoback et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Adherence and preference of intravenous zoledronic acid for osteoporosis versus other bisphosphonates
Maria Jose Fobelo Lozano et al.
EUROPEAN JOURNAL OF HOSPITAL PHARMACY (2019)
Fracture Prevention with Zoledronate in Older Women with Osteopenia
Ian R. Reid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04)
R. E. Coleman et al.
JOURNAL OF BONE ONCOLOGY (2018)
Meta-analysis of the effects of oral and intravenous dexamethasone premedication in the prevention of paclitaxel-induced allergic reactions
Fu-Chao Chen et al.
ONCOTARGET (2017)
Effect of single-dose dexamethasone on acute phase response following zoledronic acid: a randomized controlled trial
E. O. Billington et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Dexamethasone versus standard treatment for postoperative nausea and vomiting in gastrointestinal surgery: randomised controlled trial (DREAMS Trial)
R. Ravikumar et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Dexamethasone versus standard treatment for postoperative nausea and vomiting in gastrointestinal surgery: randomised controlled trial (DREAMS Trial)
R. Ravikumar et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Immune regulation by glucocorticoids
Derek W. Cain et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Paget's Disease of Bone: An Endocrine Society Clinical Practice Guideline
Frederick R. Singer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Monocytes and γδ cells control the acute-phase response to intravenous zoledronate: Insights from a phase IV safety trial
Joanne L. Welton et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
IOF Regionals – 4th Asia-Pacific Osteoporosis Meeting
OSTEOPOROSIS INTERNATIONAL (2013)
Acute phase response following intravenous zoledronate in postmenopausal women with low bone mass
Athanasios D. Anastasilakis et al.
BONE (2012)
Persistence with intravenous zoledronate in elderly patients with osteoporosis
Y. -K. Lee et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Treatment with acetaminophen/paracetamol or ibuprofen alleviates post-dose symptoms related to intravenous infusion with zoledronic acid 5 mg
J. D. Wark et al.
OSTEOPOROSIS INTERNATIONAL (2012)
No Effect of Rosuvastatin in the Zoledronate-Induced Acute-Phase Response
Polyzois Makras et al.
CALCIFIED TISSUE INTERNATIONAL (2011)
Effect of acetaminophen and fluvastatin on post-dose symptoms following infusion of zoledronic acid
S. L. Silverman et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Assessing general side effects in clinical trials: reference data from the general population
Winfried Rief et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
Characterization of and Risk Factors for the Acute-Phase Response after Zoledronic Acid
I. R. Reid et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Dose-related patterns of glucocorticoid-induced side effects
D. Huscher et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Peripheral blood monocytes are responsible for gamma delta T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP
Anke J. Roelofs et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Fracture risk with intermittent high-dose oral glucocorticoid therapy
Frank de Vries et al.
ARTHRITIS AND RHEUMATISM (2007)
The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gamma delta T cells in response to aminobisphosphonates is inhibited by statins
RE Hewitt et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
National trends in osteoporosis visits and osteoporosis treatment, 1988-2003
RS Stafford et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting
CC Apfel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Inhibition of IFN-γ signaling by glucocorticoids
XY Hu et al.
JOURNAL OF IMMUNOLOGY (2003)
分享论文
